Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for Prevention of Type 2 Diabetes in Pre-diabetic Patients
NCT01052025Phase 4Unknown
- Sponsor
- Srinakharinwirot University
- Start
- Aug 2009
- Primary completion
- Mar 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Curcumin with Placebo (2 arms). Primary endpoint: Delay of degenerative beta-cells for protection of Type 2 Diabetes at 12 months. Status: unknown.
02
Drugs
curcumin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01052025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01052025.